ENDRA Life Sciences Inc.
Organization details
- Legal name
- ENDRA Life Sciences Inc.
- Former names
- Endra Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3845 — Electromedical & Electrotherapeutic Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- ANN Arbor
- Headquarters state / province
- Michigan
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- NDRA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001681682
- EIN
- 26-0579295
Board of directors
-
Alexander Y. Tokman · Director · Chief Executive OfficerSince 2023
- Since 2023
-
Francois Roger Michelon · Director · Chief Executive OfficerSince 2023
-
Lou Basenese · DirectorSince 2023
-
Michael Harsh · DirectorSince 2023
Chief executives
Director election results
Annual meeting of December 9, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.0%
-
98.3%
-
98.3%
-
99.3%
Board connections
2 of this board's directors also sit on 4 other boards. 1 is in the same sector.
- via Anthony Digiandomenico and Lou Basenese
- via Anthony Digiandomenico
- via Anthony Digiandomenico
-
eXoZymes Inc. Same sectorvia Anthony Digiandomenico
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Alexander Y. Tokman Director, Officer (Chief Executive Officer) | Grant or award | +26,921 | — | — |
| Mar 2, 2026 | Jacroux Richard Officer (Chief Financial Officer) | Grant or award | +13,461 | — | — |
| Jan 21, 2026 | Anthony Digiandomenico Director | Grant or award | +60,324 | — | — |
| Jan 21, 2026 | Michael Harsh Director | Grant or award | +60,324 | — | — |
| Jan 21, 2026 | Jacroux Richard Officer (Chief Financial Officer) | Grant or award | +20,000 | — | — |
| Jan 21, 2026 | Lou Basenese Director | Grant or award | +60,324 | — | — |
| Jan 21, 2026 | Alexander Y. Tokman Director, Officer (Chief Executive Officer) | Grant or award | +75,000 | — | — |
| Oct 10, 2025 | Anthony Digiandomenico Director | Grant or award | +70,822 | $7.06 | $500,003 |
| Jun 11, 2025 | Lou Basenese Director | Grant or award | +5,384 | — | — |
| Jun 11, 2025 | Michael Harsh Director | Grant or award | +5,384 | — | — |
| Jun 11, 2025 | Anthony Digiandomenico Director | Grant or award | +5,384 | — | — |
| Aug 27, 2024 | UBS Group AG 10% owner | Open-market purchase | +3,715 | $0.55 | $2,043 |
| May 18, 2023 | Thornton Michael Milos Officer (Chief Technology Officer) | Open-market purchase | +15,000 | $1.65 | $24,750 |
| May 2, 2023 | Anthony Digiandomenico Director | Open-market purchase | +83,333 | $1.20 | $100,000 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about ENDRA Life Sciences Inc.
Who is the CEO of ENDRA Life Sciences Inc.?
Francois Roger Michelon is ENDRA Life Sciences Inc.'s Chief Executive Officer.
How many directors are on ENDRA Life Sciences Inc.'s board?
ENDRA Life Sciences Inc.'s board has 5 directors: Alexander Y. Tokman, Anthony Digiandomenico, Francois Roger Michelon, Lou Basenese and Michael Harsh.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="endra-life-sciences-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.